Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal  information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; SPORE in Mesothelioma, Lung, Breast and Ovarian Cancers.                    

*Date:*                         February 2-3, 2011.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Wlodek Lopaczynski, M.D., PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8131, Bethesda, MD 20892, 301-594-1402,                         *lopacw@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Development of Molecular Diagnostics Assay to Detect Basal-like Breast Cancer.                    

*Date:*                         February 15, 2011.                    

*Time:*                         12 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 703, Rockville, MD 20852, (Telephone Conference Call).                    

*Contact Person:*                         Lalita D. Palekar, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer  Institute, 6116 Executive Boulevard, Room 7141, Bethesda, MD 20892, 301-496-7575,                         *palekarl@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Systems for Automated Storage, Analysis, and Reporting of Objective Behavioral Exposures.                    

*Date:*                         February 16-17, 2011.                    

*Time:*                         8:30 a.m. to 11 a.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Ellen K Schwartz, E.D.D., M.B.A., Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8055B, Bethesda, MD 20892-8329, 301-594-1215,                         *schwarel@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment.                    

*Date:*                         February 16, 2011.                    

*Time:*                         1 p.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 8055A, Rockville, MD 20852, (Telephone Conference Call)                    

*Contact Person:*                         Zhiqiang Zou, M.D., PhD, Scientific Review Officer, National Cancer Institute, National Institutes of Health, 6116 Executive Blvd., Room 8055A, MSC 8329, Bethesda, MD 20852,                         *zouzhiq@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Smartphone Applications for Cancer Prevention and Control.                    

*Date:*                         February 17, 2011.                    

*Time:*                         1 p.m. to 3 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Ellen K Schwartz, E.D.D., M.B.A., Scientific Review Officer, Special Review & Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8055B, Bethesda, MD 20892-8329, 301-594-1215,                         *schwarel@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Nanotechnology Sensing Platforms.                    

*Date:*                         March 2, 2011.                    

*Time:*                         8 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Savvas C Makrides, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 8050a, Bethesda, MD 20892, 301-496-7421,                         *makridessc@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Innovative Technology Development.                    

*Date:*                         March 2-3, 2011.                    

*Time:*                         8 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Jeffrey E. DeClue, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8059, Bethesda, MD 20892-8329, 301-496-7904,                         *decluej@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel;                               ( print page 577)                            Nanotechnology Therapeutics and Theranostics.                    

*Date:*                         March 3, 2011.                    

*Time:*                         8 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Savvas C Makrides, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 8050a, Bethesda, MD 20892, 301-496-7421,                         *makridessc@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Development of Blood-based Methods for the Detection of Cancer Recurrence in Post-Therapy Breast Cancer Patients.                    

*Date:*                         March 3, 2011.                    

*Time:*                         12 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 703, Rockville, MD 20852, (Telephone Conference Call)                    

*Contact Person:*                         Lalita D. Palekar, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer  Institute, 6116 Executive Boulevard, Room 7141, Bethesda, MD 20892, 301-496-7575,                         *palekarl@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; High Level Programming Language to Expedite Development of User Interfaces.                    

*Date:*                         March 8, 2011.                    

*Time:*                         12 p.m. to 3 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 607, Rockville, MD 20852, (Telephone Conference Call)                    

*Contact Person:*                         Marvin L. Salin, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694,                         *msalin@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Non-Coding RNAs and Cancer.                    

*Date:*                         March 10, 2011.                    

*Time:*                         8 a.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Thomas M Vollberg, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7142, Bethesda, MD 20892, 301-594-9582,                         *vollbert@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Health Information Technology to Facilitate Patient-Centered Communication in Cancer Related Care.                    

*Date:*                         March 10, 2011.                    

*Time:*                         12 p.m. to 3 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 607, Rockville, MD 20852, (Telephone Conference Call)                    

*Contact Person:*                         Marvin L. Salin, PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer  Institute, NIH, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694,                         *msalin@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel; Multi-Center Clinical Trials.                    

*Date:*                         March 14, 2011.                    

*Time:*                         2 p.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 8103, Rockville, MD 20852, (Telephone Conference Call)                    

*Contact Person:*                         Timothy C. Meeker, M.D., PhD, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8103, Bethesda, MD 20892, (301) 594-1279,                         *meekert@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: December 28, 2010.

Anna P. Snouffer,

Deputy Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-33287 Filed 1-4-11; 8:45 am]

BILLING CODE 4140-01-P